Literature DB >> 7076022

Effect of drugs on the pulmonary changes in experimental acute pancreatitis in the rat.

A R Berry, T V Taylor.   

Abstract

Respiratory complications of acute pancreatitis are well recognised and are closely related to a poor prognosis. Using an experimental model in the rat, a decrease in lung compliance and an increase in lung weight were produced in acute pancreatitis. The effects of dexamethasone, heparin, and aspirin on these changes were studied. The mean specific lung compliance was reduced by 16% in the pancreatitis group compared with the control group (p less than 0.05) and this change was abolished by dexamethasone (p less than 0.02), heparin (p less than 0.01), and aspirin (p less than 0.001). Percentage lung weight (as percentage of total body weight) was raised by 22% in the pancreatitis group compared with the sham operation group (p less than 0.01) and this change was abolished by heparin (p less than 0.01) and aspirin (p less than 0.05), but not affected by dexamethasone (p less than 0.5). The results indicate that 'stiff' and heavy lungs occur in experimental acute pancreatitis. The fact that these changes are abolished by heparin and improved by aspirin suggests that intrapulmonary fibrin deposition is a factor in the pathogenesis of the important respiratory complications of this condition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076022      PMCID: PMC1419705          DOI: 10.1136/gut.23.6.481

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Acute respiratory distress syndrome in pancreatitis.

Authors:  B Interiano; I D Stuard; R W Hyde
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

2.  Respiratory complications in acute pancreatitis.

Authors:  J H Ranson; J W Turner; D F Roses; K M Rifkind; F C Spencer
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

3.  Respiratory insufficiency secondary to acute pancreatitis.

Authors:  J M Kellum; T R DeMeester; R C Elkins; G D Zuidema
Journal:  Ann Surg       Date:  1972-05       Impact factor: 12.969

4.  Defibrination in acute pancreatitis.

Authors:  P R Greipp; J A Brown; H R Gralnick
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  Phospholipids, acute pancreatitis, and the lungs: effect of lecithinase infusion on pulmonary surface activity in dogs.

Authors:  A P Morgan; M E Jenny; H Haessler
Journal:  Ann Surg       Date:  1968-03       Impact factor: 12.969

6.  The mechanism of pulmonary damage following traumatic shock.

Authors:  F W Blaisdell; R J Stallone
Journal:  Surg Gynecol Obstet       Date:  1970-01

Review 7.  Trends in microvascular research. The microembolism syndrome.

Authors:  T Saldeen
Journal:  Microvasc Res       Date:  1976-03       Impact factor: 3.514

8.  Pulmonary and circulatory effects of fibrinopeptides.

Authors:  T Bayley; J A Clements; A J Osbahr
Journal:  Circ Res       Date:  1967-10       Impact factor: 17.367

9.  A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis.

Authors:  H C Kwaan; M C Anderson; L Gramatica
Journal:  Surgery       Date:  1971-05       Impact factor: 3.982

10.  The relationship of coagulation factors to clinical complications of acute pancreatitis.

Authors:  J H Ranson; H Lackner; I R Berman; R Schinella
Journal:  Surgery       Date:  1977-05       Impact factor: 3.982

View more
  2 in total

1.  Changes in the biophysical properties and ultrastructure of lungs, and intrapulmonary fibrin deposition in experimental acute pancreatitis.

Authors:  A R Berry; G C Davies; A M Millar; T V Taylor
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

2.  Pulmonary involvement in chronic pancreatitis.

Authors:  G Masoero; S Spinaci; W Arossa; A Andriulli; E Gaia; G De Pretis; G Dobrilla; M De la Pierre
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.